1. 33 Commissioning and dosimetric characteristics of new halcyon system. (December 2018) Authors: Bernard, V.; Fafi, S.; Nguyen, D.; Khodri, M. Journal: Physica medica Issue: Volume 56(2018)Supplement 1 Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival. (March 2018) Authors: Dubot, C.; Bernard, V.; Sablin, M.P.; Vacher, S.; Chemlali, W.; Schnitzler, A.; Pierron, G.; Ait Rais, K.; Bessoltane, N.; Jeannot, E.; Klijanienko, J.; Mariani, O.; Jouffroy, T.; Calugaru, V.; Hoffmann, C.; Lesnik, M.; Badois, N.; Berger, F.; Le Tourneau, C.; Kamal, M. Journal: European journal of cancer Issue: Volume 91(2018) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Control of immune tolerance by the SIRPα-CD47 pathway and myeloid-derived suppressor cells. (July 2016) Authors: Poirier, N.; Pengam, S.; Dilek, N.; Claire, U.; Bernard, M.; Daguin, V.; Vanessa, G.; Gilles, B.; Bernard, V. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets. (November 2019) Authors: Moreira, A.; Masliah-Planchon, J.; Callens, C.; Vacher, S.; Lecerf, C.; Frelaut, M.; Borcoman, E.; Torossian, N.; Ricci, F.; Hescot, S.; Sablin, M.P.; Tresca, P.; Loirat, D.; Melaabi, S.; Trabelsi-Grati, O.; Pierron, G.; Gentien, D.; Bernard, V.; Vincent Salomon, A.; Servant, N. Journal: European journal of cancer Issue: Volume 121(2019) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EP-1739 Indicators evaluation for robust dose prescription in SBRT of peripheral non-small cell lung cancer. (April 2019) Authors: Beldjoudi, G.; Bernard, V.; Tanguy, R. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Experimental model of occluded biliary metal stent recanalization using irreversible electroporation via a tubular catheter. (1st January 2021) Authors: Rohan, T.; Andrasina, T.; Juza, T.; Matkulcik, P.; Červinka, D.; Svobodova, I.; Novotná, V.; Bernard, V.; Valek, V.; Goldberg, S. Nahum Journal: International journal of hyperthermia Issue: Volume 38:Number 1(2021) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P484: WHOLE EXOME SEQUENCING (WES) CHARACTERIZES THE MUTATIONAL LANDSCAPE OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN). (23rd June 2022) Authors: Witte, H.; Kuenstner, A.; Schwarting, J.; Bernard, V.; Merz, H.; von Bubnoff, N.; Busch, H.; Feller, A.; Gebauer, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗